Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × EBV-associated Tumors × Immune Checkpoint Inhibitors × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 2 Skin Neoplasms 1 Multiple Myeloma 1 Motor Activity 1 Melanoma 1 Leukemia, Myeloid, Acute 1 EBV-associated Tumors 1 Carcinoma, Merkel Cell 1 Advanced Solid Tumor 1

Interventions

Standard of Care 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07349836 2026-01-20

Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Not yet recruiting

EBV-associated Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡